136 related articles for article (PubMed ID: 1645825)
1. Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma.
Tang ZY; Zhou HY; Zhao G; Chai LM; Zhou M; Lu JZ; Liu KD; Havas HF; Nauts HC
Med Oncol Tumor Pharmacother; 1991; 8(1):23-8. PubMed ID: 1645825
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection.
Tang ZY; Liu KD; Bao YM; Lu JZ; Yu YQ; Ma ZC; Zhou XD; Yang R; Gan YH; Lin ZY
Cancer; 1990 Jan; 65(2):211-5. PubMed ID: 1688507
[TBL] [Abstract][Full Text] [Related]
3. [Multimodality treatment and two-stage resection for unresectable hepatocellular carcinoma--experimental and clinical studies].
Tang ZY
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):2-5. PubMed ID: 2163821
[TBL] [Abstract][Full Text] [Related]
4. Multimodality treatment in advanced primary liver cancer.
Zhou XD; Tang ZY; Yu YQ; Yang BH; Lu JZ; Lin ZY; Ma ZC
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():286-9. PubMed ID: 7544966
[TBL] [Abstract][Full Text] [Related]
5. [Radiotherapy alternated with chemotherapy and immunotherapy on nude mice bearing human hepatocellular carcinoma].
Bao YM
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):382-4. PubMed ID: 2470566
[TBL] [Abstract][Full Text] [Related]
6. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
[TBL] [Abstract][Full Text] [Related]
7. [Radioimmunotherapy combined with chemotherapy and immunotherapy for nude mice bearing human hepatocellular carcinoma].
Bao YM
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):245-7. PubMed ID: 2625102
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma (HCC)].
Li KD
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):430-2. PubMed ID: 1338985
[TBL] [Abstract][Full Text] [Related]
9. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
10. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein.
Fan J; Wu ZQ; Tang ZY; Zhou J; Qiu SJ; Ma ZC; Zhou XD; Ye SL
World J Gastroenterol; 2001 Feb; 7(1):28-32. PubMed ID: 11819728
[TBL] [Abstract][Full Text] [Related]
11. Salvage surgery following downstaging of unresectable hepatocellular carcinoma.
Lau WY; Ho SK; Yu SC; Lai EC; Liew CT; Leung TW
Ann Surg; 2004 Aug; 240(2):299-305. PubMed ID: 15273555
[TBL] [Abstract][Full Text] [Related]
12. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.
Roayaie S; Frischer JS; Emre SH; Fishbein TM; Sheiner PA; Sung M; Miller CM; Schwartz ME
Ann Surg; 2002 Apr; 235(4):533-9. PubMed ID: 11923610
[TBL] [Abstract][Full Text] [Related]
13. Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma.
Lau WY; Leung TW; Lai BS; Liew CT; Ho SK; Yu SC; Tang AM
Ann Surg; 2001 Feb; 233(2):236-41. PubMed ID: 11176130
[TBL] [Abstract][Full Text] [Related]
14. Results of hepatic resection and postoperative arterial chemotherapy for hepatocellular carcinoma.
Harada A; Nonami T; Kishimoto W; Nakao A; Takagi H
Cancer Chemother Pharmacol; 1992; 31 Suppl():S35-7. PubMed ID: 1333906
[TBL] [Abstract][Full Text] [Related]
15. Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma.
Epstein B; Ettinger D; Leichner PK; Order SE
Cancer; 1991 Feb; 67(4):896-900. PubMed ID: 1703915
[TBL] [Abstract][Full Text] [Related]
16. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
[TBL] [Abstract][Full Text] [Related]
17. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection.
Chan KM; Lee WC; Hung CF; Yu MC; Jan YY; Chen MF
Chang Gung Med J; 2005 Aug; 28(8):543-50. PubMed ID: 16265844
[TBL] [Abstract][Full Text] [Related]
18. Hepatic artery ligation and infusion chemotherapy for unresectable primary liver cancer.
Zhou XD; Tang ZY; Yu YQ; Ma ZC; Xu DB; Bao YM; Yang R; Zhang M; Zhou M
Chin Med J (Engl); 1991 Oct; 104(10):846-50. PubMed ID: 1661226
[TBL] [Abstract][Full Text] [Related]
19. [Arterial infusion chemotherapy and embolization in unresectable hepatocellular carcinoma using an intraarterial catheter].
Tanada M; Soga H; Kurita K; Takiyama W; Saeki H; Takashima S; Satoh G; Wada T; Jinno K; Tokuyama K
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2470-2. PubMed ID: 2843111
[TBL] [Abstract][Full Text] [Related]
20. Three decades' experience in surgery of hepatocellular carcinoma.
Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
